A groundbreaking research study exploring the potential of blood tests to diagnose dementia is underway at North Bristol NHS Trust, in collaboration with the University of Bristol, marking a significant step toward improving the UK’s dementia diagnosis rate.
This initiative, led by the READ-OUT (REAl World Dementia OUTcomes) research team at Dementias Platform UK (DPUK), seeks to address gaps in diagnosis and enhance early detection of dementia, ultimately improving outcomes for people living with the condition.
The study is part of the Blood Biomarker Challenge – a multi-million-pound programme led by Alzheimer’s Society and Alzheimer’s Research UK, supported with funds raised by players of People’s Postcode Lottery. It aims to explore whether a panel of blood tests can complement existing diagnostic pathways in NHS memory clinics, helping clinicians provide faster and more accurate diagnoses for people living with dementia.